Skip to main content

Provider

By Jessica Hagen | 01:35 pm | January 24, 2025
Ashkan Afkhami of BCG X sat down with MobiHealthNews during JPM to discuss the U.S. health system's strengths, challenges in cost control and the transformative potential of AI.
HIMSS25
By HIMSS TV | 11:14 am | January 24, 2025
Brian Gonzalez and Dr. Sarah Hoffe of Moffitt Cancer Center highlight the VR-focused research they will discuss during their HIMSS25 talk in Las Vegas. They explain how the emerging technology has benefited their clinical research efforts.
By Anthony Vecchione | 03:49 pm | January 23, 2025
The olivia app will allow patients to aggregate their health data in a central location.
By Anthony Vecchione | 03:00 pm | January 23, 2025
The aim of the partnership is to allow healthcare providers to offer precision medicine support tools.   
By Anthony Vecchione | 02:03 pm | January 23, 2025
The funds will be used to strengthen the development of its proprietary AI and enhance technology-enabled delivery of clinical trials.
By Anthony Vecchione | 01:54 pm | January 23, 2025
SpaceX's Dragon spacecraft, which recently returned from the ISS, included 50 biotechnology, physical science and student research payloads.
By Jessica Hagen | 02:37 pm | January 22, 2025
Project Stargate includes a partnership between Oracle's Larry Ellison, OpenAI's Sam Altman and SoftBank's Masayoshi Son that aims to enhance cancer detection and personalized vaccines.
By Anthony Vecchione | 12:29 pm | January 22, 2025
Bernke Papenburg, program manager of Robotics at Rijnstate Hospital in the Netherlands, previews her HIMSS25 talk, where she will discuss the challenges associated with deploying digital technology in a hospital setting.  
By Anthony Vecchione | 02:08 pm | January 21, 2025
The financing will be used to execute the company's long-term growth initiatives centered on high-margin, scalable recurring revenues across B2B and pharma channels.
By Anthony Vecchione | 01:37 pm | January 21, 2025
AMD is making a $20 million equity investment to bolster Absci's drug discovery efforts and expand AMDs accelerators and ROCm software.